SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Endocrinology Referral — George H. W. Bush

PatientGeorge H. W. Bush
Date of birth1959-06-12
IdentifiersMRN HR-ML018-SYN; SSN (made up) 000-18-7245
Document date2026-05-08
AuthorDouglas Whitford, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

New paroxysmal atrial fibrillation in a fit 66-year-old, with thyroid tests showing hyperthyroidism and a positive TSH receptor antibody. Please confirm Graves' disease, assess the eyes, and advise on definitive treatment and on the thyroid course afterwards. [S]

Urgency: Urgent, within two weeks. [S]

Questions for the consultant:

History of Present Illness

Atrial fibrillation began four days ago as unusual tiredness while running, with a fast ventricular rate on arrival at hospital. ECG showed no abnormality apart from the rhythm, and the echocardiogram was normal. Sinus rhythm returned on medication without cardioversion, with one brief recurrence before discharge. Discharged on metoprolol succinate 50 mg daily and apixaban 5 mg twice daily (CHA2DS2-VASc 1, HAS-BLED 1, shared decision). Today: sinus rhythm at 88; TSH 0.005 mIU/L, free T4 3.6 ng/dL, total T3 280 ng/dL, TSH receptor antibody 8.2 IU/L; white cell count 6.8 and neutrophils 3.9 x10³/µL; ALT 32 U/L; creatinine 0.92 mg/dL. Diffusely enlarged, non-tender thyroid; no eye signs. Never used tobacco. Methimazole 20 mg daily started today [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

4 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metoprolol succinate extended-release 50 mg oral tablet, one tablet by mouth daily (started in hospital)One tablet each morningOral route2026-05-05 to 2026-07-17stoppedS
Apixaban 5 mg oral tablet, one tablet by mouth twice daily (started in hospital)One tablet twice dailyOral route2026-05-05 to 2026-09-11stoppedS
Methimazole 10 mg oral tablet, two tablets (20 mg) by mouth dailyTwo tablets once daily; stop three days before radioactive iodineOral route2026-05-08 to 2026-05-26completedS

Problems

ProblemClinical statusVerificationCodeProvenance
Paroxysmal atrial fibrillation, first detected four days before intake while running, triggered by hyperthyroidism; CHA2DS2-VASc 1; synthetic modern episode linked to his documented atrial fibrillationactiveconfirmed I48.0S — Synthetic modern classification of a documented arrhythmia.
Graves' disease with hyperthyroidism; synthetic modern diagnosis linked to his documented Graves' diseaseactiveconfirmed E05.00S — Synthetic modern diagnosis confirmed by thyroid tests and TSH receptor antibody; the historical diagnosis is D.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
May 4, 1991Atrial fibrillation that began as unusual fatigue while running; hospital stay of two days, with normal ECG apart from the rhythm and a normal cardiac ultrasound; sinus rhythm restored on medication without cardioversionD (CLM-0002, CLM-0003, CLM-0004)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-05-08Body height188cmS
2026-05-08Body weight86kgS
2026-05-08Body mass index (BMI) [Ratio]24.3kg/m2S
2026-05-08Systolic blood pressure142mm[Hg]S
2026-05-08Diastolic blood pressure68mm[Hg]S
2026-05-08Heart rate88/minS
2026-05-08Respiratory rate16/minS
2026-05-08Body temperature37.1CelS
2026-05-08Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-05-08Thyrotropin [Units/volume] in Serum or Plasma0.005m[IU]/L0.4-4 mIU/LLowS
2026-05-08Thyroxine (T4) free [Mass/volume] in Serum or Plasma3.6ng/dL0.8-1.8 ng/dLHighS
2026-05-08Triiodothyronine (T3) [Mass/volume] in Serum or Plasma280ng/dL80-200 ng/dLHighS
2026-05-08Thyrotropin receptor Ab [Units/volume] in Serum8.2[IU]/L<=1.75 [IU]/LHighS
2026-05-08Leukocytes [#/volume] in Blood by Automated count6.810*3/uL4-11 10*3/uLNormalS
2026-05-08Neutrophils [#/volume] in Blood by Automated count3.910*3/uL1.5-7.5 10*3/uLNormalS
2026-05-08Hemoglobin [Mass/volume] in Blood14.8g/dL13.5-17.5 g/dLNormalS
2026-05-08Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma32U/L7-55 U/LNormalS
2026-05-08Creatinine [Mass/volume] in Serum or Plasma0.92mg/dL0.7-1.3 mg/dLNormalS
2026-05-08Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M87mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-05-08Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS

Assessment

Plan of Treatment